Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
GLP-1 Agonists: Supporting Success with Nutrition and Lifestyle Considerations (1 hour) CE/CME Course #: 25-397 This course reviews clinical evidence for glucagon-like peptide-1 (GLP-1) receptor agonists for conditions including type 2 diabetes and weight loss
While these are still just preliminary findings, they set the class up for expansion into more indications, further increasing its market potential
A randomized study to compare the effects of once-weekly dulaglutide injection and once-daily glimepiride on glucose fluctuation of type 2 diabetes mellitus patients: A 26-week follow-up
If you have experience with other peptides, the process is familiar
New York: Garland Science (2002)
GLP-1 drugs seem to fight addiction by reducing the hormone dopamine in a brain system involved in reward, motivation and stress a system "that is co-opted or hijacked, if you will, by addiction," Al-Aly says
